BATS | ETF
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements.
The fund invests predominantly in common stock.
Although it may invest across economic sectors, the fund concentrates its investments in health care related industries.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 8.43% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 6.41% |
| KRYS | Krystal Biotech Inc | Healthcare | Biotechnology | 5.98% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 4.35% |
| LGND | Ligand Pharmaceuticals Incorporated | Healthcare | Biotechnology | 4.00% |
| BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 3.70% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 3.10% |
| ADPT | Adaptive Biotechnologies Corp | Healthcare | Diagnostics & Research | 3.05% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 2.95% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 2.89% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 2.80% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 2.77% |
| AZN_old | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 2.77% |
| 207940 | Samsung Biologics Co Ltd | Healthcare | Biotechnology | 2.76% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 2.61% |
| CTVA | Corteva Inc | Basic Materials | Agricultural Inputs | 2.44% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 2.23% |
| TVTX | Travere Therapeutics Inc | Healthcare | Biotechnology | 2.13% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 2.13% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.12% |